Evoking plasmin for β-amyloid clearance  

作　　者：Jian Zhao Gang Pei 

机构地区：[1]Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China [2]School of Life Science and Technology, Tongji University, Shanghai 200092, China

出　　处：《Cell Research》2008年第8期803-804,共2页细胞研究（英文版）

摘　　要：Alzheimer＇s disease （AD） is a progressive neurodegenerative disorder and the most common cause of dementia. It is estimated that there are currently about 18 million people worldwide suffering from Alzheimer＇s disease, and this number will double by 2 025 to 34 millions （http：//www.alz.org）. Enormous efforts have been taken to identify key molecular events underlying AD pathogenesis and seek for measures to postpone the onset and progression of, if not prevent the disease.

关 键 词：血纤维蛋白溶酶 阿尔茨海默氏痴呆 细胞基因 基因研究 

分 类 号：R749.16[医药卫生—神经病学与精神病学]